|Bid||3.79 x 3000|
|Ask||4.39 x 1100|
|Day's Range||3.78 - 4.13|
|52 Week Range||3.76 - 6.54|
|PE Ratio (TTM)||N/A|
|Earnings Date||Oct 24, 2018 - Oct 29, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||8.00|
If you’re interested in Trinity Biotech plc (NASDAQ:TRIB), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock couldRead More...
DUBLIN, Ireland, July 19, 2018-- Trinity Biotech plc, a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the ...
Trinity Biotech (NASDAQ: TRIB ) announces its next round of earnings this Thursday. Here is Benzinga's everything-that-matters guide for the Q2 earnings announcement. Earnings and Revenue Trinity Biotech ...
DUBLIN, Ireland, July 12, 2018-- Trinity Biotech plc, a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for ...
Assessing Trinity Biotech plc’s (NASDAQ:TRIB) performance as a company requires looking at more than just a years’ earnings data. Below, I will run you through a simple sense check toRead More...
The World Health Organization published this month a list of 113 “essential” in vitro diagnostics to guide member states in establishing standards for universal health coverage, inform donation selection ...
NEW YORK, NY / ACCESSWIRE / March 7, 2018 / Trinity Biotech Plc Sponsored ADR Class A (NASDAQ: TRIB ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 7, 2018, at ...
Categories: Yahoo FinanceGet free summary analysis Trinity Biotech Plc reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Trinity Biotech Plc – Abbott Laboratories, Danaher Corporation and Thermo Fisher Scientific Inc. (ABT-US, DHR-US and TMO-US) that have also reported for this period. Highlights Summary numbers: Revenues ... Read more (Read more...)